Zoledronic acid for primary breast cancer (BCC238)
Your shopping cart is empty.
This booklet is about the bisphosphonate drug zoledronic acid given to treat primary breast cancer. It explains what it is, who might be offered it and the side effects it can cause.
Last reviewed April 2019; next review 2021.
Breast Cancer Care merged with Breast Cancer Now in April 2019. From October 2019 the new merged charity is called Breast Cancer Now.
However, lots of our patient information will continue to appear under the legacy brand Breast Cancer Care until new editions are produced. Please be assured that, whether the information you order or download is branded as Breast Cancer Care or Breast Cancer Now, the quality remains the same.
Stay in touch
We'd love to keep in touch about news, events and how you can get involved. To hear from us, please sign up below.